(1,2N) and (3,2N)-carbocyclic-2-amino tetralin derivatives

Details (1,2N) and (3,2N)-carbocyclic-2-amino tetralin derivatives (1,2N) and (3,2N)-carbocyclic-2-amino tetralin derivatives

1991-12-04

1996-02-13

Rizzo, Nicholas

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

546 99, 548427, 548450, C07D20960, A61K 3140

Patent

active

054912369

ABSTRACT:
This invention is therapeutically useful tetralins and pharmaceutically acceptable acid addition salts thereof of the formula ##STR1## wherein R, R.sub.1 and A are as defined in claim 1. These compounds are useful to treat central nervous system disorders.

REFERENCES:
patent: 4234731 (1980-11-01), Kavadias
patent: 4618683 (1986-10-01), De Bernadis et al.
patent: 5030636 (1991-07-01), Imhof et al.
patent: 5180733 (1993-01-01), Basha et al.
patent: 5244888 (1993-09-01), De Bernards et al.
patent: 5248677 (1993-09-01), Basha et al.
patent: 5318966 (1994-06-01), Brudener et al.
patent: 5318967 (1994-06-01), Brudener et al.
A. Kumar, et al., "Studies on analgesic-narcotic antagonists: synthesis of N-substituted 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]-quinolines", p. 456, abstract 5285g, Chemical Abstracts, vol. 86, 1977 & Indian J. Chem, Sect. B 1976 14B(7), 556-7.
H. Wikstrom et al., "N-substituted 1,2,3,4,4a,5,6,10b-octhydrobenzo[f]quinolines and 3-phenylpiperindes: effects on central dopamine and .beta.receptors", pp. 2169-2174 (see compounds 11-33) Journal of Medicnal Chemistry, vol. 30, No. 12, 1987, American Chemical Society.
J. G. Cannon et al., "Rigid congeners of dopamine based on octahydrobenzo[f]quinoline: peripheral and central effects" pp. 341-347 (see compounds 1-7, 13-16) Journal of Medicinal Chemistry, vol. 22, No. 4, 1979, American Chemical Society.
J. G. Cannon et al., "Congeners of the .beta.conformer of dopamine derived from cis-- and trans-octahydrobenzo[f]quinoline and trans-octahrydrobenzo[f]quinoline and trans-octahydrobenzo[g]quinoline", pp. 1-5 (see Table I), Journal of Medicinal Chemistry, vol. 213, No. 1, Jan. 1980, American Chemical Society.
H. Wikstrom et al., "Monophenolic octahydrobenzo[f]quinolines: central dopamine-- and serotonin-receptor stimulating activity" pp. 925-931 (see compounds 6-19) Journal of Medicinal Chemistry, vol. 25, No. 8, 1982 American Chemical Society.
J. G. Cannon et al., "Conformationally restriced congeners of dopamine derived from octahydrobenzo[g]quinoline and octahydrobenzo[f]quinoline " pp. 190-195 (see compounds 16, 42-50) Journal of Medicinal Chemistry, vol. 27, No. 2, 1984, American Chemical Society.
J. G. Cannon et al., "p-dimethoxy-substituted trans-octahydrobenzo[f]and --[g ]quinolines: synthesis and assessment of dopaminergic agonist effects" pp. 2529-2534 (see compounds 8,9,13)Journal of Medicinal Chemistry, vol. 29, No. 12, 1986, American Chemical Society.
J. G. Cannon et al., "Assessment of a potential dopaminergic prodrug moiety in several ring systems", pp. 2016-2020(see compounds 4a-4d) Journal of Medicinal Chemistry, vol. 29, No. 10, 1986, American Chemical Society.
H. Wikstrom et al., "Resolved cis-10-hydroxy-4-n-propyl-1,2,3,4,4a,5,6,10b-octahydrobenzo f quinoline: central serotonin stimulating properties"pp. 1567-1573 (see p. 1567) Journal of Medicinal Chemistry, vol. 30, No. 9, Sep. 1987, American Chemical Society.

Affiliated with

Also associated with

Rating

(1,2N) and (3,2N)-carbocyclic-2-amino tetralin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with (1,2N) and (3,2N)-carbocyclic-2-amino tetralin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (1,2N) and (3,2N)-carbocyclic-2-amino tetralin derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-241602